Mega brand potential: Huons launches powder stick format of bestselling probiotics for menopausal health

By Tingmin Koe contact

- Last updated on GMT

South Korean firm Huons has developed probiotics for relieving menopausal symptoms. ©Getty Images
South Korean firm Huons has developed probiotics for relieving menopausal symptoms. ©Getty Images

Related tags: South korea, Menopause, Probiotics

South Korean biotech company Huons has launched a powder stick version of its flagship product Elruby Menolacto, a probiotic said to alleviate menopausal symptoms.

The product was originally launched as a capsule​ in South Korea in last April. It contains the firm’s proprietary strain Lactobacillus acidophilus ​YT1 developed with the Korea Food Research Institute. 

menolacto probiotics 2
Menolacto capsule

The strain works by promoting the expression of estrogen receptor beta, in turn alleviating menopausal symptoms arising from low estrogen level.

The product claims to 1) benefit the health of women undergoing menopause 2) support the proliferation of lactobacilli ​and regulate the number of harmful bacteria 3) support smooth bowel movement and 4) support gut health.

A 12-week RCT evaluating the effectiveness and safety of the probiotic had been conducted, showing that the Kupperman Index (KMI) – which measures the severity of 11 menopausal symptoms – saw a significant drop of 66 per cent in the group which took the probiotic.

The powder stick version, available in sweet apple flavour, can be consumed directly without water.

Each stick contains a CFU count of 100 million and also consists of ingredients such as chicory root extract, vitamin C, vitamin D3, pomegranate extract, red ginseng concentrate, and safflower seed extract. The recommended intake is one stick per day.

It was launched on GS My Shop – a TV shopping platform last month. Each box contains 15 powder sticks.

The launch of the powder stick follows the recent success of its capsule version.

Based on the company’s latest announcement, its overall Q1 financial performance was led by its health functional foods business.

In fact, Elruby Menolacto in capsule form was the company’s key sales driver with an annual sale of KRW$7.4bn (US$6.5m).

This is over 40 per cent of the company’s functional food sales of KRW$17.4bn (US$15.4m).

Its sales performance showed that it has the “potential for growth as a mega brand”,​ the company said.

As a whole, the company, Huons Global, recorded sales of KRW$133.2bn (US$118m), with an operating profit of KRW$20.5bn (US$18m) in Q1 this year, which were 13 per cent and nine per cent respectively higher as compared to the same period last year.

Aside from Huons – which consists of the health functional food portfolio – Huons  Global also includes other businesses such as Humedix – which manufactures hyaluronic filler elravie for cosmetic surgery and Huons Medicare – which is into the sanitising and disinfectant medical supply business.

Moving forward, there are plans to enter the health functional foods D2C business through Huons online mall, and this is part of the strategy to strengthen its competitiveness in the business.

Related news

Related products

show more

Pycnogenol® Offers Dual Mode of Action for Skin

Pycnogenol® Offers Dual Mode of Action for Skin

Horphag Research | 22-Mar-2021 | Clinical Study

In multiple clinical studies, Pycnogenol® was shown to stimulate production of new collagen and hyaluronic acid in the skin. The super-antioxidant also...

BENTONE GELS® for D5-Free Formulas

BENTONE GELS® for D5-Free Formulas

Elementis | 26-Nov-2019 | Product Brochure

Newest SILICONE offering for D5 alternative formulations BENTONE GELS create a light texture with dewy finish. An improved spreadability of 30% higher...

Related suppliers

Follow us

Products

View more

Webinars